|
|
 |
|
Viewing report
|
|
|
|
Biosensors International Group, Ltd. (B20) - Product Pipeline Analysis
GlobalData, Aug 2011, Pages: 44
Biosensors International Group, Ltd. (B20) - Product Pipeline Analysis
Summary
Biosensors International Group, Ltd. (Biosensors) is engaged in the development, manufacture and marketing of innovative medical devices utilized in interventional cardiology and critical care procedures. The company develops drug-eluting stents (DES) and a pipeline of next-generation products set to gain market share from traditional therapies such as conventional drug eluting stents, bare-metal stent and open-heart surgery. It is also focused on the technology addressing a DES system, including the stent, delivery catheter, polymer and proprietary drug. The company operates in Singapore, Switzerland, China, the US, Japan, Indonesia, and the Netherlands. Biosensors is headquartered in Singapore.
This report is a source for data, analysis and actionable intelligence on the Biosensors International Group, Ltd. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Customers who bought this item also bought
Abbott Vascular Inc. - Product Pipeline Analysis
XTENT, Inc. (XTNT) - Product Pipeline Analysis
Elixir Medical Corporation - Product Pipeline Analysis
Medtronic, Inc. (MDT) - Product Pipeline Analysis
Eurocor GmbH - Product Pipeline Analysis
MicroPort Scientific Corporation (853) - Product Pipeline Analysis
Medlogics Device Corporation - Product Pipeline Analysis
SurModics, Inc. (SRDX) - Product Pipeline Analysis
Aachen Resonance GmbH - Product Pipeline Analysis
Flexible Stenting Solutions Inc. - Product Pipeline Analysis
|
|
|
|
